Bruce D. Gelb, MD, of Mount Sinai School of Medicine, Elected to the Institute of Medicine
Dr. Bruce Gelb was among 65 new members and five foreign associates announced today at the IOM’s 40th annual meeting.
Bruce D. Gelb, MD, Director of the Child Health and Development Institute at Mount Sinai School of Medicine, has been elected to the Institute of Medicine (IOM), the health arm of the National Academy of Sciences. Dr. Gelb was among 65 new members and five foreign associates announced today at the IOM’s 40th annual meeting.
Election to the IOM honors individuals who have demonstrated outstanding professional achievement and commitment to service in the fields of health and medicine. The IOM serves as a national resource for the government and private industry on issues concerning medicine, biomedical sciences, health, and health care. Dr. Gelb joins 10 members of Mount Sinai’s faculty who are IOM members.
"As an internationally renowned pediatric translational researcher, Dr. Gelb’s election to the IOM is well deserved," said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. "His extraordinary work, including the initiation of his molecular cardiology/genetics program and his discovery of genes for several human genetic traits, are a major asset to Mount Sinai."
Dr. Gelb is the current Program Chair for the Pediatric Academic Societies, the largest international pediatric scientific meeting and is a member of the Federal Advisory Committee for the National Children’s Study, which provides advice and recommendations to the Director of the National Institutes of Health, the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Director of the National Children’s Study regarding critical aspects of the Study.
At Mount Sinai, Dr. Gelb and his team of researchers identified the first gene for a relatively common Mendelian trait, Noonan syndrome. He showed that that gene is an important oncogene for childhood leukemias. Dr. Gelb’s work has led to the identification of a new disease class, the so-called RASopathies, which comprises several genetic traits. His studies have been published in journals such as Cell and Nature.
"This is a tremendous honor for me and it’s wonderful for Mount Sinai," said Dr. Gelb, who is also the Gogel Family Professor of Child Health and Development and Professor of Pediatrics, as well as Genetics and Genomic Sciences. "The number of faculty here who are IOM members certainly speaks to the excellence of this institution. There are seven pediatricians alone from Mount Sinai who are IOM members, which is remarkable. It is that translational research strength upon which we are building the new Child Health and Development Institute."
In 2006, Dr. Gelb developed the Center for Molecular Cardiology at Mount Sinai to focus more broadly on congenital heart defects. Dr. Gelb’s group is studying congenital heart defects as a complex genetic trait as part of the National Heart Lung and Blood Institute’s (NHBLI) Pediatric Cardiac Genomics Consortium. Dr. Gelb is also the Mount Sinai site Principal Investigator for the NHBLI-funded clinical study comparing losartan to atenolol for aortic aneursym in Marfan syndrome.
Dr. Gelb completed his pediatric residency at Babies Hospital of Columbia-Presbyterian Medical Center, followed by a pediatric cardiology fellowship at Texas Children’s Hospital at the Baylor College of Medicine. After completing his fellowship at Mount Sinai, Dr. Gelb joined the faculty in 1991.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2009, U.S. News & World Report ranked The Mount Sinai Hospital among the nation’s top 20 hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit www.mountsinai.org.